BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38606661)

  • 41. Two novel blood-based biomarker candidates measuring degradation of tau are associated with dementia: A prospective study.
    Neergaard JS; Dragsbæk K; Christiansen C; Karsdal MA; Brix S; Henriksen K
    PLoS One; 2018; 13(4):e0194802. PubMed ID: 29641555
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Blood biomarkers of traumatic brain injury and cognitive impairment in older veterans.
    Peltz CB; Kenney K; Gill J; Diaz-Arrastia R; Gardner RC; Yaffe K
    Neurology; 2020 Sep; 95(9):e1126-e1133. PubMed ID: 32571850
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders.
    Palmqvist S; Janelidze S; Quiroz YT; Zetterberg H; Lopera F; Stomrud E; Su Y; Chen Y; Serrano GE; Leuzy A; Mattsson-Carlgren N; Strandberg O; Smith R; Villegas A; Sepulveda-Falla D; Chai X; Proctor NK; Beach TG; Blennow K; Dage JL; Reiman EM; Hansson O
    JAMA; 2020 Aug; 324(8):772-781. PubMed ID: 32722745
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dynamics of plasma biomarkers in Down syndrome: the relative levels of Aβ42 decrease with age, whereas NT1 tau and NfL increase.
    Mengel D; Liu W; Glynn RJ; Selkoe DJ; Strydom A; Lai F; Rosas HD; Torres A; Patsiogiannis V; Skotko B; Walsh DM
    Alzheimers Res Ther; 2020 Mar; 12(1):27. PubMed ID: 32192521
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma biomarkers predict Alzheimer's disease before clinical onset in Chinese cohorts.
    Cai H; Pang Y; Fu X; Ren Z; Jia L
    Nat Commun; 2023 Oct; 14(1):6747. PubMed ID: 37875471
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The relationship between plasma biomarkers and amyloid PET in dementia with Lewy bodies.
    Donaghy PC; Firbank M; Petrides G; Lloyd J; Barnett N; Olsen K; Heslegrave A; Zetterberg H; Thomas AJ; O'Brien JT
    Parkinsonism Relat Disord; 2022 Aug; 101():111-116. PubMed ID: 35872565
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma biomarkers and genetics in the diagnosis and prediction of Alzheimer's disease.
    Stevenson-Hoare J; Heslegrave A; Leonenko G; Fathalla D; Bellou E; Luckcuck L; Marshall R; Sims R; Morgan BP; Hardy J; de Strooper B; Williams J; Zetterberg H; Escott-Price V
    Brain; 2023 Feb; 146(2):690-699. PubMed ID: 35383826
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
    Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K;
    Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trajectories of CSF and plasma biomarkers across Alzheimer's disease continuum: disease staging by NF-L, p-tau181, and GFAP.
    Wojdała AL; Bellomo G; Gaetani L; Toja A; Chipi E; Shan D; Chiasserini D; Parnetti L
    Neurobiol Dis; 2023 Dec; 189():106356. PubMed ID: 37977432
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease.
    Chatterjee P; Pedrini S; Ashton NJ; Tegg M; Goozee K; Singh AK; Karikari TK; Simrén J; Vanmechelen E; Armstrong NJ; Hone E; Asih PR; Taddei K; Doré V; Villemagne VL; Sohrabi HR; Zetterberg H; Masters CL; Blennow K; Martins RN
    Alzheimers Dement; 2022 Jun; 18(6):1141-1154. PubMed ID: 34494715
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multiplex immunoassay measurement of amyloid-β
    Vogelgsang J; Shahpasand-Kroner H; Vogelgsang R; Streit F; Vukovich R; Wiltfang J
    Exp Brain Res; 2018 May; 236(5):1241-1250. PubMed ID: 29480353
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increases of Plasma Levels of Glial Fibrillary Acidic Protein, Tau, and Amyloid β up to 90 Days after Traumatic Brain Injury.
    Bogoslovsky T; Wilson D; Chen Y; Hanlon D; Gill J; Jeromin A; Song L; Moore C; Gong Y; Kenney K; Diaz-Arrastia R
    J Neurotrauma; 2017 Jan; 34(1):66-73. PubMed ID: 27312416
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Remote Blood Biomarkers of Longitudinal Cognitive Outcomes in a Population Study.
    Rajan KB; Aggarwal NT; McAninch EA; Weuve J; Barnes LL; Wilson RS; DeCarli C; Evans DA
    Ann Neurol; 2020 Dec; 88(6):1065-1076. PubMed ID: 32799383
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationship between topological efficiency of white matter structural connectome and plasma biomarkers across the Alzheimer's disease continuum.
    Zhang M; Chen H; Huang W; Guo T; Ma G; Han Y; Shu N
    Hum Brain Mapp; 2024 Jan; 45(1):e26566. PubMed ID: 38224535
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Potential Value of Plasma Amyloid-β, Total Tau, and Neurofilament Light for Identification of Early Alzheimer's Disease.
    Shi Y; Lu X; Zhang L; Shu H; Gu L; Wang Z; Gao L; Zhu J; Zhang H; Zhou D; Zhang Z
    ACS Chem Neurosci; 2019 Aug; 10(8):3479-3485. PubMed ID: 31145586
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combining plasma Aβ and p-tau217 improves detection of brain amyloid in non-demented elderly.
    Niimi Y; Janelidze S; Sato K; Tomita N; Tsukamoto T; Kato T; Yoshiyama K; Kowa H; Iwata A; Ihara R; Suzuki K; Kasuga K; Ikeuchi T; Ishii K; Ito K; Nakamura A; Senda M; Day TA; Burnham SC; Iaccarino L; Pontecorvo MJ; Hansson O; Iwatsubo T
    Alzheimers Res Ther; 2024 May; 16(1):115. PubMed ID: 38778353
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of acute sleep loss on diurnal plasma dynamics of CNS health biomarkers in young men.
    Benedict C; Blennow K; Zetterberg H; Cedernaes J
    Neurology; 2020 Mar; 94(11):e1181-e1189. PubMed ID: 31915189
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma neurofilament light chain and glial fibrillary acidic protein predict stroke in CADASIL.
    Chen CH; Cheng YW; Chen YF; Tang SC; Jeng JS
    J Neuroinflammation; 2020 Apr; 17(1):124. PubMed ID: 32321529
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer's disease pathology and clinical disease progression.
    Clark C; Lewczuk P; Kornhuber J; Richiardi J; Maréchal B; Karikari TK; Blennow K; Zetterberg H; Popp J
    Alzheimers Res Ther; 2021 Mar; 13(1):65. PubMed ID: 33766131
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ventricular Electrocardiographic Signatures Associated with Dementia and Plasma Alzheimer's Disease Biomarkers in Older Adults: A Population-Based Study.
    Mao M; Wang C; Hou T; Han X; Liu R; Han Q; Dong Y; Wang J; Liu C; Cong L; Imahori Y; Vetrano DL; Wang Y; Du Y; Qiu C
    J Alzheimers Dis; 2023; 94(4):1515-1526. PubMed ID: 37424464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.